Stay updated on Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial page.

Latest updates to the Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2, indicating a minor metadata update to the page record.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision label on the page updated from v3.6.0 to v3.6.2, signaling an updated version of the study record page. It does not modify the study details or any user-facing content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRecruitment status is updated to no longer looking for participants, and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. Header labeling for interventions was updated from Intervention / Treatment to Intervention/Treatment, and the revision/version badge advanced from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check36 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a platform release; no substantive study information appears to be affected.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision tag updated from v3.5.3 to v3.5.4, indicating a new build of the page. This update does not alter the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now shows a newer ClinicalTrials.gov revision/version number (Revision: v3.5.3 instead of v3.5.0). This represents an update to the site build/release rather than a change to the trial information.SummaryDifference0.1%

Stay in the know with updates to Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Hyperthermia Immunotherapy in Abdominal-Pelvic Malignancies Clinical Trial page.